GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 233 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $418,000 | +54.8% | 9,641 | +125.3% | 0.07% | +65.9% |
Q2 2020 | $270,000 | -35.3% | 4,279 | -50.2% | 0.04% | -43.8% |
Q3 2019 | $417,000 | +12.7% | 8,600 | -11.6% | 0.07% | +43.1% |
Q3 2018 | $370,000 | +4.5% | 9,734 | +32.8% | 0.05% | -3.8% |
Q1 2018 | $354,000 | +72.7% | 7,328 | +10.6% | 0.05% | +60.6% |
Q3 2017 | $205,000 | – | 6,627 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 595,473 | $25,790,000 | 4.19% |
Grace Capital | 131,549 | $5,697,000 | 3.60% |
Fernwood Investment Management, LLC | 201,657 | $8,734,000 | 3.44% |
Fairmount Funds Management LLC | 215,000 | $9,312,000 | 3.33% |
Arctis Global LLC | 293,700 | $12,720,000 | 2.74% |
Perceptive Advisors | 5,674,711 | $245,771,000 | 2.64% |
ArchPoint Investors | 217,510 | $9,420,000 | 2.61% |
Alerce Investment Management, L.P. | 126,270 | $5,469,000 | 2.15% |
Profit Investment Management, LLC | 42,196 | $1,826,000 | 1.17% |
Affinity Asset Advisors, LLC | 50,000 | $2,166,000 | 1.15% |